ATE476205T1 - Implantierbare vaskuläre vorrichtung zur abgabe von topotecan in kombination mit rapamycin - Google Patents

Implantierbare vaskuläre vorrichtung zur abgabe von topotecan in kombination mit rapamycin

Info

Publication number
ATE476205T1
ATE476205T1 AT05251389T AT05251389T ATE476205T1 AT E476205 T1 ATE476205 T1 AT E476205T1 AT 05251389 T AT05251389 T AT 05251389T AT 05251389 T AT05251389 T AT 05251389T AT E476205 T1 ATE476205 T1 AT E476205T1
Authority
AT
Austria
Prior art keywords
devices
agents
compounds
medical device
utilized
Prior art date
Application number
AT05251389T
Other languages
English (en)
Inventor
Robert Falotico
Tom Jay Parry
Jonathon Z Zhao
Original Assignee
Cordis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cordis Corp filed Critical Cordis Corp
Application granted granted Critical
Publication of ATE476205T1 publication Critical patent/ATE476205T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05251389T 2004-03-09 2005-03-08 Implantierbare vaskuläre vorrichtung zur abgabe von topotecan in kombination mit rapamycin ATE476205T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/796,397 US8828416B2 (en) 2004-03-09 2004-03-09 Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury

Publications (1)

Publication Number Publication Date
ATE476205T1 true ATE476205T1 (de) 2010-08-15

Family

ID=34827610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05251389T ATE476205T1 (de) 2004-03-09 2005-03-08 Implantierbare vaskuläre vorrichtung zur abgabe von topotecan in kombination mit rapamycin

Country Status (7)

Country Link
US (1) US8828416B2 (de)
EP (1) EP1574228B1 (de)
JP (1) JP5042458B2 (de)
CN (1) CN1679573B (de)
AT (1) ATE476205T1 (de)
CA (1) CA2499691C (de)
DE (1) DE602005022645D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US7419678B2 (en) * 2000-05-12 2008-09-02 Cordis Corporation Coated medical devices for the prevention and treatment of vascular disease
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
EP1610823B1 (de) 2003-03-28 2011-09-28 Innovational Holdings, LLC Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
WO2005030091A2 (en) * 2003-09-25 2005-04-07 Scios Inc. Stents and intra-luminal prostheses containing map kinase inhibitors
US8747881B2 (en) 2003-12-19 2014-06-10 Cordis Corporation Intraluminal medical devices in combination with therapeutic agents
US20050249776A1 (en) * 2003-12-19 2005-11-10 Chen Chao C Coated aneurysmal repair device
US8652502B2 (en) * 2003-12-19 2014-02-18 Cordis Corporation Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
DE102004024552B3 (de) * 2004-05-18 2005-12-08 Infineon Technologies Ag Speicherzellenanordnung mit einer Doppel-Speicherzelle
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
EP1933785B1 (de) * 2005-10-14 2015-04-22 Abbott Laboratories Zusammensetzungen, systeme, kits und verfahren zur verabreichung von rapamycin-analoga mit paclitaxel unter verwendung von medizinprodukten
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US20160279297A1 (en) * 2013-10-22 2016-09-29 ConcieValve LLC Methods for inhibiting stenosis, obstruction, or calcification of a stented heart valve or bioprosthesis
CN113384390B (zh) 2015-09-15 2023-08-22 萨维奇医疗股份有限公司 用于在组织腔中锚定护套的装置和方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3959078A (en) 1973-05-18 1976-05-25 Midwest Research Institute Enzyme immobilization with a thermochemical-photochemical bifunctional agent
SU1088712A1 (ru) 1979-11-14 1984-04-30 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Аппарат дл циркул рного сшивани кровеносных сосудов
US4366819A (en) 1980-11-17 1983-01-04 Kaster Robert L Anastomotic fitting
US4368736A (en) 1980-11-17 1983-01-18 Kaster Robert L Anastomotic fitting
US4917091A (en) 1982-06-24 1990-04-17 Unilink Ab Annular fastening means
SE431609B (sv) 1982-06-24 1984-02-20 Unilink Ab Kirurgiskt instrument for astadkommande av anastomos och festelement herfor
US4722906A (en) 1982-09-29 1988-02-02 Bio-Metric Systems, Inc. Binding reagents and methods
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
JPH0393520A (ja) 1989-09-07 1991-04-18 Tokan Kogyo Co Ltd 感温プラスチック成形体
JPH04559A (ja) 1990-04-17 1992-01-06 Toshiba Corp データ検索方式
US5234447A (en) 1990-08-28 1993-08-10 Robert L. Kaster Side-to-end vascular anastomotic staple apparatus
US5350800A (en) 1993-01-19 1994-09-27 Medtronic, Inc. Method for improving the biocompatibility of solid surfaces
US5308641A (en) 1993-01-19 1994-05-03 Medtronic, Inc. Biocompatibility of solid surfaces
US5229172A (en) 1993-01-19 1993-07-20 Medtronic, Inc. Modification of polymeric surface by graft polymerization
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6120536A (en) 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
US5677286A (en) * 1995-04-27 1997-10-14 The University Of Michigan Glycosylated analogs of camptothecin
EP1226796B1 (de) 1997-02-03 2005-06-01 Angioguard, Inc. Gefässfilter
US20030129215A1 (en) 1998-09-24 2003-07-10 T-Ram, Inc. Medical devices containing rapamycin analogs
US6890546B2 (en) * 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
US6485514B1 (en) * 1997-12-12 2002-11-26 Supergen, Inc. Local delivery of therapeutic agents
US6425898B1 (en) 1998-03-13 2002-07-30 Cordis Corporation Delivery apparatus for a self-expanding stent
WO2000000238A1 (en) * 1998-06-26 2000-01-06 Quanam Medical Corporation Topoisomerase inhibitors for prevention of restenosis
US6153252A (en) 1998-06-30 2000-11-28 Ethicon, Inc. Process for coating stents
US6601233B1 (en) * 1999-07-30 2003-07-29 Accenture Llp Business components framework
US20070032853A1 (en) * 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
ATE407676T1 (de) * 2000-02-28 2008-09-15 Univ British Columbia Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
CA2424029C (en) * 2000-09-29 2008-01-29 Cordis Corporation Coated medical devices
US6663662B2 (en) * 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
GB0103668D0 (en) * 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
DE10127011A1 (de) 2001-06-05 2002-12-12 Jomed Gmbh Implantate mit FK506
EP1273314A1 (de) 2001-07-06 2003-01-08 Terumo Kabushiki Kaisha Stent
JP2003093520A (ja) * 2001-07-06 2003-04-02 Terumo Corp ステント
US20050065595A1 (en) 2001-09-03 2005-03-24 David Chaplin Implants containing combretastatin a-4
US7195640B2 (en) * 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US7108701B2 (en) * 2001-09-28 2006-09-19 Ethicon, Inc. Drug releasing anastomosis devices and methods for treating anastomotic sites
US20030065382A1 (en) * 2001-10-02 2003-04-03 Fischell Robert E. Means and method for the treatment of coronary artery obstructions
CN1568166A (zh) 2001-10-15 2005-01-19 荷姆泰克股份有限公司 预防再狭窄的涂层支架
US7318945B2 (en) 2003-07-09 2008-01-15 Medtronic Vascular, Inc. Laminated drug-polymer coated stent having dipped layers
US20050033417A1 (en) * 2003-07-31 2005-02-10 John Borges Coating for controlled release of a therapeutic agent

Also Published As

Publication number Publication date
EP1574228B1 (de) 2010-08-04
US20050202059A1 (en) 2005-09-15
JP2005253972A (ja) 2005-09-22
CN1679573A (zh) 2005-10-12
CA2499691C (en) 2010-06-15
CN1679573B (zh) 2010-09-29
CA2499691A1 (en) 2005-09-09
US8828416B2 (en) 2014-09-09
JP5042458B2 (ja) 2012-10-03
EP1574228A3 (de) 2006-01-25
EP1574228A2 (de) 2005-09-14
DE602005022645D1 (de) 2010-09-16

Similar Documents

Publication Publication Date Title
ATE442169T1 (de) Lokale, vaskuläre verabreichung von cladribin in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen
EP2286848A3 (de) Lokale vaskuläre Abgabe von Mycophenolsäure in Kombination mit Rapamycin zur Verhinderung von Restenose
ATE474610T1 (de) Lokale, vaskuläre verabreichung von 2- methoxyestradiol in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen
EP1582225A3 (de) Arzneimittelabgabevorrichtung
EP1591108A3 (de) Formulierungen von Sirolimus und seine Analoge in Lösungsform zur Behandlung von koronaren Herzkrankheit
EP1568387A3 (de) Beschichtung mit strahlenschützender Verbindung für medizinische Geräte
EP1723976A3 (de) Therapeutische Mittel enthaltend intraluminale Instrumente
CA2490170A1 (en) Local vascular delivery of trichostatin a alone or in combination with sirolimus to prevent restenosis following vascular injury
EP3056229A3 (de) Lokale verabreichung einer kombination von rapamycin und 17-beta-estradiol zur behandlung von vulnerabler plaque
CA2467797A1 (en) Increased biocompatibility of implantable medical devices
ATE475438T1 (de) Lokale, vaskuläre verabreichung von etoposide in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen
EP1974758A3 (de) Lokale, vaskuläre Versorgung von Probucol allein oder in Kombination mit Sirolimus zur Behandlung der Restenose, empfindlichem Plaque, AAA und Schlaganfall
ATE358505T1 (de) Beschichtete endovaskuläre vorrichtung
EP1749545A3 (de) System zur Behandlung von Aneurysmen
MXPA03006825A (es) Dispositivos vasculares revestidos.
ATE339227T1 (de) Beschichtetes medizinsches implantat zur behandlung von gefässerkrankungen
CA2462479A1 (en) Modified delivery device for coated medical devices
US7906133B2 (en) Optimized dosing for drug coated stents
ATE476205T1 (de) Implantierbare vaskuläre vorrichtung zur abgabe von topotecan in kombination mit rapamycin
EP2042202A3 (de) Lokale vaskuläre Abgabe von mTOR-Inhibitoren in Kombination mit von Peroxisom-Proliferatoren aktivierten Rezeptorstimulatoren
MXPA03003869A (es) Dispositivos medicos revestidos.
EP1586338A3 (de) Verwendung von Antioxidantien zur Verhinderung von Oxidation und zur Reduzierung von Wirkstoffzersetzung in wirkstoffhaltigen medizinischen Artikeln
WO2005034852A3 (en) Protein biomaterials and biocoacervates and methods of making and using thereof
DK1809349T3 (da) Biokompatibel coating til medicinske indretninger omfattende molekylsier
EP2196226A3 (de) Beschichtete medizinische Geräte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties